Autonomous AI Oncology Billing for New York Practices
Automate oncology revenue cycle management across New York. MedSynthea combines Oncology clinical coding rules with New York commercial and Medicaid payer policies to eliminate claim denials and accelerate reimbursement.
Oncology practices face the highest prior authorization burden in medicine — 94% of oncologists report PA delays that cause patients to abandon or postpone treatment (ASCO 2024).
New York Healthcare Market
Dense hospital and specialist market governed by NY surprise billing laws and complex Medicaid HMO rules.
Drug not on payer formulary
In New York, drug not on payer formulary is especially prevalent due to payer policies from Empire BlueCross BlueShield. Oncology practices see a 19% industry denial rate, with payer adjudication averaging 52 days.
EHR Integration in NY
Oncology clinics in New York heavily utilize epic, flatiron, veeva with SMART on FHIR write-back. MedSynthea integrates with all three for zero manual re-entry.
Oncology RCM demands specialty-grade precision: chemotherapy infusion claims (CPT 96413, 96415) must document drug dose, route, duration, and NCCN guideline compliance to survive payer review. MedSynthea pre-checks formulary status against 900+ payer drug lists before biologics are ordered, submits prior authorization packages with clinical evidence links within minutes, and tracks drug-specific coverage determinations under Medicare Part B vs Part D to prevent split-billing errors.
How MedSynthea Works for Oncology Practices in New York
Tailored RCM rules built for your specific medical specialty and state payer environment.
Specialty Coding Precision
MedSynthea's CODE agent automates coding for CPT 96400-96549 (Chemo infusion), validating codes against local coverage determinations (LCDs) and NCCI edit rules with 100% evidence links.
Local Payer Rules
Configured for Empire BlueCross BlueShield, Excellus BCBS, Fidelis Care, Healthfirst and New York State Medicaid, eliminating authorization bottlenecks and eligibility errors pre-submission.
FAQs — Oncology Billing in New York
How does MedSynthea address Oncology billing in New York?
MedSynthea combines specialty-specific CPT 96400-96549 (Chemo infusion) coding intelligence with New York-specific payer rules for Empire BlueCross BlueShield and Excellus BCBS, eliminating drug not on payer formulary defects. The Oncology industry denial rate of 19% can be reduced to under 3% with MedSynthea's predictive RISK agent.
Which New York payers are supported for Oncology?
Supported payers in New York include Empire BlueCross BlueShield, Excellus BCBS, Fidelis Care, Healthfirst, alongside New York State Medicaid. MedSynthea's ELIG agent queries 900+ payer databases in real time, verifying Oncology coverage criteria and authorization requirements in under 2 seconds.
What CPT codes does MedSynthea automate for Oncology in New York?
MedSynthea automates CPT 96400-96549 (Chemo infusion) for Oncology practices in New York, validating codes against local coverage determinations (LCDs) and NCCI edit rules. Drug not on payer formulary — the top denial cause — is intercepted before submission by the CODE agent.
How does New York State Medicaid handle Oncology billing differently?
New York State Medicaid requires strict prior authorization, specific modifier attachments, and timely filing limits for Oncology. MedSynthea's ELIG and CODE agents handle these state-specific nuances automatically, including New York-specific fee schedule application.
What is the typical reimbursement timeline for Oncology practices in New York?
Oncology practices in New York face an average reimbursement lag of 52 days industry-wide. MedSynthea's FLW (Follow-Up) agent tracks claim status continuously and initiates automated 277 EDI inquiries when payer adjudication windows expire, reducing AR days below 30.
Automate Oncology Billing in New York
See how our 9 AI agents work together for New York healthcare providers.
Book a Demo